Literature DB >> 16674337

Panel 2: methodological issues in conducting pharmacoeconomic evaluations--modeling studies.

J Hay1, J Jackson.   

Abstract

Year:  1999        PMID： 16674337     DOI： 10.1046/j.1524-4733.1999.02203.x

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  7 in total

Review 1.  Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment.

Authors:  Zoë Philips; Laura Bojke; Mark Sculpher; Karl Claxton; Su Golder
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 2.  Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models.

Authors:  Alan Haycox
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures.

Authors:  L Si; T M Winzenberg; A J Palmer
Journal:  Osteoporos Int       Date:  2013-10-24       Impact factor: 4.507

Review 4.  Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models.

Authors:  Brendan L Limone; William L Baker; Jeffrey Kluger; Craig I Coleman
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

5.  Cost-effectiveness of different human papillomavirus vaccines in Singapore.

Authors:  Vernon J Lee; Sun Kuie Tay; Yee Leong Teoh; Mei Yin Tok
Journal:  BMC Public Health       Date:  2011-03-31       Impact factor: 3.295

6.  Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge.

Authors:  Michelle Tew; Michael Willis; Christian Asseburg; Hayley Bennett; Alan Brennan; Talitha Feenstra; James Gahn; Alastair Gray; Laura Heathcote; William H Herman; Deanna Isaman; Shihchen Kuo; Mark Lamotte; José Leal; Phil McEwan; Andreas Nilsson; Andrew J Palmer; Rishi Patel; Daniel Pollard; Mafalda Ramos; Fabian Sailer; Wendelin Schramm; Hui Shao; Lizheng Shi; Lei Si; Harry J Smolen; Chloe Thomas; An Tran-Duy; Chunting Yang; Wen Ye; Xueting Yu; Ping Zhang; Philip Clarke
Journal:  Med Decis Making       Date:  2021-12-15       Impact factor: 2.749

7.  Modeling the impact of antiretroviral use in developing countries.

Authors:  Stefano M Bertozzi; Sergio Bautista-Arredondo
Journal:  PLoS Med       Date:  2006-03-14       Impact factor: 11.069
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.